Tina Glisovic‐Aplenc

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

Karen L. Bride, Tiffaney L. Vincent, Soo-Yeon Im et al. · Blood · 2018 · 221 citations · Full text

CD38 as a pan-hematologic target for chimeric antigen receptor T cells

Tina Glisovic‐Aplenc, Caroline Diorio, John Chukinas et al. · Blood Advances · 2023 · 55 citations · Full text

Hematological Malignancy, Cell Therapy, Autoimmune Disease +15

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Amber K Hamilton, Alexander B. Radaoui, Matthew Tsang et al. · Cancer Cell · 2024 · 17 citations · Full text

Neuro-oncology, Receptor Tyrosine Kinase, Immunology +9

Improved surfaceome coverage with a label‐free nonaffinity‐purified workflow

Tina Glisovic‐Aplenc, Saar Gill, Lynn A. Spruce et al. · PROTEOMICS · 2017 · 11 citations · Full text

Protein Function, Engineering, Pm/cell Surface +14